Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gráinne Donnellan"'
Autor:
Nicolette M. Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J. Murtha, Catarina Kollmannsberger, Edmond M. Kwan, Karan Parekh, Elena Schönlau, Cecily Q. Bernales, Gráinne Donnellan, Sarah W. S. Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L. Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J. Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H. Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P. van Erp, Bram De Laere, Johan Lindberg, Henrik Grönberg, Daniel J. Khalaf, Matti Annala, Kim N. Chi, Alexander W. Wyatt
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract No consensus strategies exist for prognosticating metastatic castration-resistant prostate cancer (mCRPC). Circulating tumor DNA fraction (ctDNA%) is increasingly reported by commercial and laboratory tests but its utility for risk stratific
Externí odkaz:
https://doaj.org/article/6914ec1e3ba942ee99b1463117270db9
Autor:
Alexander W. Wyatt, Nielka P. van Erp, Niven Mehra, Jack A. Schalken, Inge M. van Oort, Diederik M. Somford, Paul Hamberg, Guillemette E. Benoist, Cameron Herberts, Gráinne Donnellan, Matti Annala, Sarah W.S. Ng, Edmond M. Kwan, Takayuki Sumiyoshi, Emmy Boerrigter, Sofie H. Tolmeijer
On-treatment ctDNA fraction, PSA and LDH changes and durability of treatment response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a11a412de9ed939861799acb340754c
https://doi.org/10.1158/1078-0432.22651593.v1
https://doi.org/10.1158/1078-0432.22651593.v1
Autor:
Alexander W. Wyatt, Nielka P. van Erp, Niven Mehra, Jack A. Schalken, Inge M. van Oort, Diederik M. Somford, Paul Hamberg, Guillemette E. Benoist, Cameron Herberts, Gráinne Donnellan, Matti Annala, Sarah W.S. Ng, Edmond M. Kwan, Takayuki Sumiyoshi, Emmy Boerrigter, Sofie H. Tolmeijer
Purpose:Androgen receptor pathway inhibitors (ARPI) are standard of care for treatment-naïve metastatic castration-resistant prostate cancer (mCRPC), but rapid resistance is common. Early identification of resistance will improve management strategi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37213978670e6d02d971947533fecd1c
https://doi.org/10.1158/1078-0432.c.6604890.v1
https://doi.org/10.1158/1078-0432.c.6604890.v1
Autor:
Alexander W. Wyatt, Nielka P. van Erp, Niven Mehra, Jack A. Schalken, Inge M. van Oort, Diederik M. Somford, Paul Hamberg, Guillemette E. Benoist, Cameron Herberts, Gráinne Donnellan, Matti Annala, Sarah W.S. Ng, Edmond M. Kwan, Takayuki Sumiyoshi, Emmy Boerrigter, Sofie H. Tolmeijer
Additional methodological details
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644034b3e8a2388d2b2141127761b770
https://doi.org/10.1158/1078-0432.22651569
https://doi.org/10.1158/1078-0432.22651569
Autor:
Alexander W. Wyatt, Nielka P. van Erp, Niven Mehra, Jack A. Schalken, Inge M. van Oort, Diederik M. Somford, Paul Hamberg, Guillemette E. Benoist, Cameron Herberts, Gráinne Donnellan, Matti Annala, Sarah W.S. Ng, Edmond M. Kwan, Takayuki Sumiyoshi, Emmy Boerrigter, Sofie H. Tolmeijer
Multivariable Cox proportional hazards models for time to progression and time to death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ee2598225b0581dbce39e50de9a63e
https://doi.org/10.1158/1078-0432.22651560.v1
https://doi.org/10.1158/1078-0432.22651560.v1
Autor:
Corinne Maurice-Dror, Nicolette Fonseca, Cameron Herberts, Edmond Michael Kwan, Catarina Kollmannsberger, Wilson Tu, Daniel Joseph Khalaf, Matti Annala, Elena Schönlau, Cecily Q. Bernales, Gráinne Donnellan, Joanna Vergidis, Krista Noonan, Daygen L. Finch, Muhammad Zulfiqar, Miller Stacy, Alexander William Wyatt, Kim N. Chi
Publikováno v:
Journal of Clinical Oncology. 40:5055-5055
5055 Background: Deleterious alterations in tumor suppressor genes (TSGs) TP53, RB1, and PTEN are potential markers of small cell neuroendocrine prostate cancer (SCNP), and androgen receptor pathway inhibitor (ARPI) resistance. We examined the outcom